Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 17 pseudogene 7 (KRT17P7) is a genomic locus formally classified as a pseudogene at the keratin 17 locus[4]. Unlike the canonical keratin 17 gene (KRT17), which encodes the type I intermediate filament protein *keratin 17* involved in skin, nail, and hair structure[1][6], KRT17P7 is not transcribed into a functional protein. No evidence supports a biological, disease, or pharmacological role for KRT17P7. Key distinction: - *KRT17 (Keratin 17)* is a protein-coding gene implicated in diseases such as pachyonychia congenita and steatocystoma multiplex, and functions in structural support, wound healing, and epithelial development[1][3][5][6]. - *KRT17P7* is a **pseudogene**, meaning it does **not** produce functional protein and should **not be considered a therapeutic or research target**[4]. If you seek structured information about keratin 17 as a biological target, please refer specifically to **KRT17** (keratin 17), not **KRT17P7**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 17 pseudogene 7 (KRT17P7).